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Background: To date, elective nephron-sparing surgery is an established method for the exstirpation of renal
tumors. While open partial nephrectomy remains the reference standard of the management of renal masses,
laparoscopic partial nephrectomy (LPN) continues to evolve. Conventional techniques include clamping the renal
vessels risking ischaemic damage of the clamped organ. Thus, new techniques are needed that combine a
sufficient tissue incision for exstirpation of the tumor with an efficient coagulation to assure haemostasis and
abandon renal vessel clamping in LPN. Laser-excision of renal tumors during laparoscopic surgery seems to be a
logical solution.
Methods: We performed nephron-sparing surgery without clamping of the renal vessels in 11 patients with a renal
tumor in exophytic position (mean size 32 mm, ranging 8–45 mm) by laser-supported LPN.
Results: Regular ultrasound monitoring and insertion of a temporary drainage showed no evidence of
postoperative hemorrhage. All tumors were removed with a histopathologically confirmed surrounding margin of
normal renal tissue (R0 resection). Serum creatinine, hemoglobin, and hematocrit were nearly unaltered before and
after surgery.
Conclusions: The experience won in these patients have confirmed that laser-assisted LPN without clamping of
the renal vessels could be a safe and gentle alternative to classic partial nephrectomy in patients with exophytic
position of renal tumors.
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To date, therapy of renal cell carcinoma (RCC) by partial
nephrectomy for small and peripheral located renal
tumors is a prevailing method. Due to the equal
tumorspecific survival and a lower incidence of postop-
erative kidney malfunction (e.g. chronic renal failure,
proteinuria) it has proven to be superior to radical neph-
rectomy [1-3]. Another important approach in kidney
tumor treatment is laparoscopic partial nephrectomy. It
is a safe, well described technique [4] and a particularly
gentle operation method [5-8].
To achieve bloodless operating conditions, the renal ves-
sels are usually clamped during open and laparoscopic
tumor resection. Old or predamaged organs often fail to* Correspondence: hagen.loertzer@med.uni-goettingen.de
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reproduction in any medium, provided the orcompensate the renal ischaemia caused by clamping the
renal vessels [9]. Accordingly greater morbidity regarding
acute and chronic renal failure compared to radical tumor
nephrectomy was noted [10]. While organ preservation is
achieved, diminished renal function may result from tissue
hypoxia.
Warm ischaemia time seems to be extended in laparo-
scopic partial nephrectomy compared to open surgery
[11]. As renal damage is proportional to warm ischaemia
time [8,12] diminishing ischaemia might improve results
of laparoscopic partial nephrectomy. Therefore, a tech-
nique is required that assures tumor excision under
bloodless conditions without clamping the renal vessels.
A combination of sufficient tissue incision with an
efficient coagulation for assured haemostasis is essential.
To date, the commonly used techniques in laparoscopic
kidney surgery for cutting only partially fulfil thesel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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techniques and approaches that shall reduce warm is-
chaemia time in LPN [13]. They consider the reliability
and the haemostatic performance of existing sealants
and techniques used for LPN not high enough to rely
on. They demand for a new technique that makes all
laparoscopic intervention safe and feasible [13]. The es-
tablishment of laser in urology provides a new surgical
technique that combines both. We herein present our
results using laser in laparoscopic partial nephrectomy
without clamping the renal vessels.Method
The 2.0-μm continuous wave laser (RevoLix TM) by
LISA laser was used, a diode pumped solid-state laser
emitting a wavelength of 2013 nm. The laser penetrates
tissue to a depth of about 0.5 mm. The coagulative and
ablative tissue effects are gentle. Tumor resection was
performed with a safety margin of at least 2 mm. 11 pa-
tients (6 female and 5 male; age range 35 – 72, median
61 years) were treated. Included in this prospective study
were patients that presented with a suspected malignant
renal mass of unknown histology that had been inciden-
tally found in routine ultrasound examination. Subsequent
computer tomography scans (Figure 1) revealed that all
tumors were located in the renal periphery. We applied
the R.E.N.A.L. Nephrometry Score for risk evaluation and
quantification of the renal masses [14]. Patients with a sin-
gle kidney, centrally located renal tumors and recurrence
of a former tumor were excluded. Exclusion criterias were
revision procedure, ASA-score>= 3, centrally located
tumor, R.E.N.A.L.-Score >9 and (functional) single kidney.
All patients gave an informed consent after being given
detailed information about the planned procedure. The
application of the laser was approved for LISA laser under
the approval no. 17-447 (UMDNS).Figure 1 CT-scan with a 19 × 22 mm exophytic tumor of the
right kidney located in the renal polar lines, 4–7 mm away
from the sinus or collecting system; R.E.N.A.L.-Nephrometry
Score: 7a [R(1)+E(1)+N(2)+A(a)+L(3)= 7a].After informed consent all patients received transperitoneal
laparoscopic partial nephrectomy and laser-resection of
the tumor using a power of 40 W. A transperitoneal lap-
aroscopic technique was used, utilisizing one Visiport™
trocar (Covidien Germany, Neustadt an der Donau) and
2 – 3 VersaStep™ Plus trocars (Covidien Germany,
Neustadt an der Donau), ports were located as illus-
trated in Figure 2. The transperitoneal procedure in-
cluded complete mobilisation and preparation of the
kidney with the renal hilum. No clamping of the renal
vessels was performed. A directed haemostasis could be
done with 15 W.
Results
The operation time for the partial nephrectomy was less
than 20 min with a mean overall operation time of 115
min (range: 85–175 min). Time needed for resection of
the tumor with the laser fibre averaged 195 sec (range
100 – 320 sec). All tumors were extirpated with a safety
margin of at least 2 mm surrounding the tumor tissue. No
resection bleeding occurred that had to be treated by a
Lahodny suture. Two patients were treated with hemostatic
gauze (Tachotamp®, Ethicon, Nordheim, Germany) which
was placed onto the resection area.
Mean loss of blood was 75 ml (10 – 400 ml). Postopera-
tive follow-up was uncomplicated in all cases. Regularly
performed ultrasound monitoring and drainages inserted
during operation showed no secondary haemorrhage.
Drainages were removed one day post operatively. Moni-
tored serum creatinine, hemoglobin, and hematocrit were
nearly unaltered pre and post-surgery. Patient’s pre-
and postoperative serum creatinine differed at an aver-
age of 18 μmol/l (range: -11 to 120 μmol/l), respectively.
Pre- and postoperative hemoglobin differed at a meanFigure 2 Position of the trocars for the laparoscopic procedure.
A) Trocar for camera introduction: 12 mm Visiport™ trocar B) 10 mm
VersaStep™ Plus trocar C) 5 mm VersaStepTM Plus trocar, D) optional
5 mm VersaStep™ Plus trocar; (all trocars used are from Covidien
Germany, Neustadt an der Donau).
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hospitalisation was 5 days.
All of the tumors scored below 9 points according to
the R.E.N.A.L. Nephrometry score. According to the
score maximum (R)adius was 2 pts (45 mm in diameter),
(E)xophytic/endophytic status scored max 2 pts (more
than 50% endophytic) and the distance to the collecting
system was always more than 5mm, resulting in a (N)
earness score of 2 pts. A large number of the tumors
treated was located crossing the polar line or in between
the polar lines, (L)ocation score max. 3 pts.
Resected tumor size averaged 32 mm (range: 8 to
45 mm) (Table 1).
Histological analysis demonstrated that all malignant
tumor masses (7/11 clear cell RCC) were resected with a
safety margin of normal renal tissue (R0 resection)
(Table 1). In two patients an angiomyolipoma was found,
in one patient an oncocytom and one patient was diag-
nosed a haemorrhagic renal cyst. The renal pelvis
remained closed throughout every operation. Due to the
minimal distance between laser fiber tip and renal tissue
a smooth incision and a definite discrimination between
tumor and kidney as well as identification of small
vessels was possible (Figures 3 and 4).
Discussion
Conventional nephron sparing surgery includes clamping
the renal vessels which is followed by ischaemia in the
remnant renal tissue. Especially predamaged organs often
fail to compensate the caused hypoxia which leads to an
increased morbidity regarding acute and renal failure [10].
Within the first 5–8 min oxidative radicals are formed in
the hypoxic tissue leading to damage [15,16]. Therefore,
ischaemia should be avoided. Studies indicate that ischae-
mia free tumor exstirpation result in a better clinical out-
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* study includes 9 patients – one laparoscopic and 8 open partial nephrectomies.
** only referring to the one case in which a renal tumor was found, the other LPN w
*** 13 patients were treated with laser assisted techniques– 5 open partial nephrec
and 5 transperitoneal laparoscopic partial nephrectomies, in one open partial nephhas been shown to be a safe and especially gentle method
[5-7]. However, warm ischaemia time seems to be ex-
tended compared to open surgery [11]. The use of lasers
to support laparoscopic exstirpation might diminish this
disadvantage in peripheral renal tumors. Whilst laser has
made its way into varius fields of medicine and urology it
has still remained experimental in kidney surgery. Re-
cently, both experimental and in vivo results of laser-
supported open partial nephrectomy using different laser
types have been reported [17-22]. Laser-assisted LPN in
turn was published only in few clinical cases [18,20,22,23].
Mattioli et al. first reported their experience with the
Revolix laser in laparoscopic partial nephrectomy in one
case with clampage of the renal pedicle [20]. Lotan et al.
successfully performed 3 laser-assisted laparoscopic partial
nephrectomies without clampage of the renal vessels using
a holmium YAG laser [23]. They favourably assessed the
haemostatic and cutting capacities of laser but criticize the
disadvantage of smoke combustion during resection [23].
Indeed, we observed that resecting small renal tumors
by means of laser-supported laparoscopy causes a lot of
smoke due to the coagulation heat and combustion of
tissue (Figure 3). This strongly impairs the visibility.
Using an additional trocar to draw of the smoke by a
sucker for laparoscopic instruments we assured a safe
resection without causing a tumor burst in our study
(Figure 4). Khoder et al. recently published their results
of a diode laser emitting at a wavelength of 1,318 nm
containing 5 cases of laser-assisted LPN and 3 laser-
assisted retroperitoneoscopic partial nephrectomies
with clamping the vessels in 2 cases. They studied dif-
ferent laser powers in laser- supported renal resection
and also favourably assessed the use of the laser for
exstirpation of peripheral renal tumors particularly for
laparoscopic resection [18]. In all of our 11 presented
cases, resection of tumor masses performed by laser-; WOI –Without ischaemia time)
ia time (LPN) Laser Power




WOI Holmium-YAG- Laser 0,2 J/Puls with 60 Puls/min
0,4J/Puls with 55 Puls/min
0,8J7Puls with 40 Puls/min
WWI
; 19 & 24 min)
WOI
diode laser, 1318 nm
wavelength; continuous
wave mode
45 – 70 Watt
WOI RevoLix 2 μm diode laser;
2013 nm wavelength;
continuous wave mode
30 Watt (cutting) 15
Watt (coagulation)
ere performed on a renal cyst and a function-less pol of a kidney.
tomies and 8 LPN, laparoscopic procedures containing 3 retroperitoneoscopic
rectomy the tumor margin was found positiv.
Figure 3 Smoke occurring due to the coagulation heat and
combustion of tissue during the laser resection of a tumor of
the right kidney.
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vessels which makes our series the currently largest
study to this topic (Table 1).
The physical properties of lasers define and limit their
mode of application in surgery: deep tissue penetration
goes along with a greater risk of accidental destruction
of surrounding tissue like renal or pararenal tissue or
even renal hilum. Another important characteristic is
the coagulation capacity. The diode-pumped solid-state
laser we used in this study shows a relatively shallow
penetration depth (0.5 mm). Compared to this, using a
CO2- or Er: YAG-laser only allows coagulation and
tissue penetrations up to a depth of 1–10 μm, enabling a
better preparation of deeper stuctures. However, the
coagulation capacities of these lasers are very low
[22,24]. Other laser types, e.g. the Nd: YAG-laser, areFigure 4 Resection of a 3 cm diameter tumor of the right
kidney with an accurate resection margin and optimal
coagulation. The smoke is eliminated with a sucker.not suitable for renal surgery because of their penetra-
tion depths of up to 10 cm [24]. The diode-pumped
solid-state laser we used in this study possesses an opti-
mal combination of efficient coagulation capacity and
shallow tissue penetration ensuring a gentle and secure
preparation of structures, e.g. tumor capsule, without
cutting it accidentally [17,22]. In our study resection was
performed with a power of 30 W. The used laser adjust-
ment in a moderate cut velocity (1–3 mm/s) is sufficient
for adequate manipulation (cutting as well as preparation)
(Figure 4). By means of 15W smaller vessels were suc-
cessfully coagulated. Efficient and safe vascular coagu-
lation was possible up to a vessel diameter of 1.5 mm.
Using a lower power increased coagulation but less resec-
tion is attained. This agrees with the results Gruschwitz
et al. published using the 2 μm continous wave laser
(RevoLix™) for open laser-supported resection of small
renal tumors [17].
The operative risk was relatively easily assessable by
using the R.E.N.A.L. Nephrometry score. Using an on-
line calculator (e.g. on http://www.nephrometry.com/
index.htm) made this a fast and effective method
[25,26]. Particularly suitable for laser-supported partial
laparoscopic nephrectomy without clamping the renal
vessels were tumors with a R.E.N.A.L. Nephrometry
score of 4–5 pts. A higher score requires an advanced
experience in laparoscopic partial nephrectomy [25].
Many critics of laser-assisted partial nephrectomy
often criticize that histopathological analysis of resection
margins might be not possible. Our results and those of
others refute this [17]. Histological analysis in our study
demonstrates that all malignant tumor masses were
resected with a safety margin of at least 2 mm of healthy
renal tissue. The presented clinical results are compar-
able to the published literature of open and laparoscopic
partial nephrectomy [17,23,27].
The limitations of this experimental study are clearly
set by the small cohort. For validation of this new
method, multi-center studies are needed that include a
long-term follow up. We herein present the results of
our small experimental mono-center study.
Taking into account our results and those of others we
conclude that laser-supported LPN without clamping
the renal vessels seem to be a safe method for the resec-
tion of peripheral and small renal tumors with few com-
plications. The short operating time, the minimal loss of
blood and the lack of vessel clamping represent the
advantage of laser-assisted LPN.
Conclusion
Laparoscopic laser-supported partial nephrectomy with-
out clamping the renal vessels seems to be a reasonable
alternative to conventional open partial nephrectomy.
This new and gentle operation method could be of
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elderly patients and those with an imperative indication
for nephron-sparing surgery.
Our new method combines the advantages of minimal-
invasive laparoscopic partial nephrectomy with the pre-
vention of parenchymal damage by warm ischaemia. By
means of absence of ischaemia and the resulting renal
damage global renal function can be preserved.
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